ArticleHematology reports2020

Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with

Yusuke Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.